share_log

HOOKIPA Pharma | DEF 14A: Definitive information statements

HOOKIPA Pharma | DEF 14A: Definitive information statements

HOOKIPA Pharma | DEF 14A：股東委託書決議
美股sec公告 ·  04/27 04:06
牛牛AI助理已提取核心訊息
HOOKIPA Pharma Inc. announced the scheduling of its 2024 Annual Meeting of Stockholders to be held virtually on June 17, 2024. The meeting will address several key proposals, including the election of two Class II directors, the ratification of PwC Wirtschaftsprüfung GmbH as the independent auditor for the fiscal year ending December 31, 2024, and amendments to the company's certificate of incorporation to increase authorized shares of common stock to 400,000,000 and to effect a reverse stock split in the range of 1-for-2 to 1-for-10. The meeting will also cover any other business properly brought before the meeting. Stockholders are invited to attend online and vote electronically. The Notice of Annual Meeting and Proxy Statement detailing the agenda were dated April 26, 2024, with plans to mail the notice on the same date. The proxy materials are accessible at www.proxyvote.com, and stockholders are encouraged to review and cast their votes promptly.
HOOKIPA Pharma Inc. announced the scheduling of its 2024 Annual Meeting of Stockholders to be held virtually on June 17, 2024. The meeting will address several key proposals, including the election of two Class II directors, the ratification of PwC Wirtschaftsprüfung GmbH as the independent auditor for the fiscal year ending December 31, 2024, and amendments to the company's certificate of incorporation to increase authorized shares of common stock to 400,000,000 and to effect a reverse stock split in the range of 1-for-2 to 1-for-10. The meeting will also cover any other business properly brought before the meeting. Stockholders are invited to attend online and vote electronically. The Notice of Annual Meeting and Proxy Statement detailing the agenda were dated April 26, 2024, with plans to mail the notice on the same date. The proxy materials are accessible at www.proxyvote.com, and stockholders are encouraged to review and cast their votes promptly.
HOOKIPA Pharma Inc. 宣佈其2024年年度股東大會定於2024年6月17日虛擬舉行。會議將討論幾項關鍵提案，包括選舉兩名二類董事，批准普華永道經濟審計有限責任公司爲截至2024年12月31日的財政年度的獨立核數師，以及修改公司註冊證書，將普通股的法定股份增加到4億股，並以1比2至1比10的比例進行反向股票分割。會議還將涵蓋在會議之前適當提出的任何其他事項。邀請股東在線參加並進行電子投票。詳細說明議程的年會通知和委託聲明的日期爲2024年4月26日，並計劃在同一天郵寄通知。代理材料可在www.proxyvote.com上查閱，鼓勵股東立即審查並投票。
HOOKIPA Pharma Inc. 宣佈其2024年年度股東大會定於2024年6月17日虛擬舉行。會議將討論幾項關鍵提案，包括選舉兩名二類董事，批准普華永道經濟審計有限責任公司爲截至2024年12月31日的財政年度的獨立核數師，以及修改公司註冊證書，將普通股的法定股份增加到4億股，並以1比2至1比10的比例進行反向股票分割。會議還將涵蓋在會議之前適當提出的任何其他事項。邀請股東在線參加並進行電子投票。詳細說明議程的年會通知和委託聲明的日期爲2024年4月26日，並計劃在同一天郵寄通知。代理材料可在www.proxyvote.com上查閱，鼓勵股東立即審查並投票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。